Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.

Zhang ZZ, Liu YJ, Yin XL, Zhan P, Gu Y, Ni XZ.

World J Gastroenterol. 2013 Mar 28;19(12):1968-74. doi: 10.3748/wjg.v19.i12.1968.

2.

Development of serous ovarian cancer is associated with the expression of homologous recombination pathway proteins.

Ye Q, Chen L, Yin X, Liu YJ, Ji Q, Zhao E.

Pathol Oncol Res. 2014 Oct;20(4):931-8. doi: 10.1007/s12253-014-9776-8. Epub 2014 Apr 22.

3.

Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.

Wei J, Costa C, Shen J, Yu L, Sanchez JJ, Qian X, Sun X, Zou Z, Gimenez-Capitan A, Yue G, Guan W, Rosell R, Liu B.

Br J Cancer. 2014 May 27;110(11):2662-8. doi: 10.1038/bjc.2014.231. Epub 2014 May 8.

4.
5.
6.

Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.

Kim JW, Im SA, Kim MA, Cho HJ, Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Lee HJ, Kim TY, Yang HK, Kim WH, Bang YJ.

Int J Cancer. 2014 Jan 1;134(1):72-80. doi: 10.1002/ijc.28245. Epub 2013 Sep 17.

7.

DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value.

Lee HE, Han N, Kim MA, Lee HS, Yang HK, Lee BL, Kim WH.

Pathobiology. 2014;81(1):25-35. doi: 10.1159/000351072. Epub 2013 Aug 21.

8.

Mutation at intronic repeats of the ataxia-telangiectasia mutated (ATM) gene and ATM protein loss in primary gastric cancer with microsatellite instability.

Kim HS, Choi SI, Min HL, Kim MA, Kim WH.

PLoS One. 2013 Dec 6;8(12):e82769. doi: 10.1371/journal.pone.0082769. eCollection 2013.

9.

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy.

Patel AN, Goyal S, Wu H, Schiff D, Moran MS, Haffty BG.

Breast Cancer Res Treat. 2011 Apr;126(3):601-7. doi: 10.1007/s10549-010-0960-6. Epub 2010 Jun 3.

PMID:
20521098
10.

Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.

Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ.

World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.

11.

mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.

Wei J, Costa C, Ding Y, Zou Z, Yu L, Sanchez JJ, Qian X, Chen H, Gimenez-Capitan A, Meng F, Moran T, Benlloch S, Taron M, Rosell R, Liu B.

J Natl Cancer Inst. 2011 Oct 19;103(20):1552-6. doi: 10.1093/jnci/djr326. Epub 2011 Aug 23.

PMID:
21862729
12.

Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.

Lv H, Cui A, Sun F, Zhang Y, Li Y, Li L, Lin Z.

Exp Mol Pathol. 2014 Aug;97(1):74-80. doi: 10.1016/j.yexmp.2014.05.007. Epub 2014 May 24.

PMID:
24866365
13.

High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma.

Hu BS, Yu HF, Zhao G, Zha TZ.

Int J Clin Exp Pathol. 2012;5(7):668-73. Epub 2012 Sep 5.

14.

Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.

Zhang XL, Yang YS, Xu DP, Qu JH, Guo MZ, Gong Y, Huang J.

World J Surg. 2009 Oct;33(10):2112-8. doi: 10.1007/s00268-009-0142-z.

PMID:
19636613
15.

Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer.

Kang B, Guo RF, Tan XH, Zhao M, Tang ZB, Lu YY.

Mutat Res. 2008 Feb 1;638(1-2):17-25. Epub 2007 Sep 1.

PMID:
17928013
16.

Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.

Cui M, Yu W, Dong J, Chen J, Zhang X, Liu Y.

Med Oncol. 2010 Sep;27(3):632-9. doi: 10.1007/s12032-009-9260-6. Epub 2009 Jun 25.

PMID:
19554484
17.

Correlation between BRCA1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer.

Gachechiladze M, Uberall I, Kolek V, Klein J, Krejci V, Stastna J, Radova L, Fridman E, Skarda J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Sep;157(3):227-32. doi: 10.5507/bp.2012.099. Epub 2012 Nov 1.

18.

Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT.

Genes Dev. 2000 Dec 1;14(23):2989-3002.

19.

Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.

Albarakati N, Abdel-Fatah TM, Doherty R, Russell R, Agarwal D, Moseley P, Perry C, Arora A, Alsubhi N, Seedhouse C, Rakha EA, Green A, Ball G, Chan S, Caldas C, Ellis IO, Madhusudan S.

Mol Oncol. 2015 Jan;9(1):204-17. doi: 10.1016/j.molonc.2014.08.001. Epub 2014 Aug 27.

20.

MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Zhang F, Bick G, Park JY, Andreassen PR.

J Cell Sci. 2012 Dec 15;125(Pt 24):6049-57. doi: 10.1242/jcs.111872. Epub 2012 Oct 4.

Supplemental Content

Support Center